Showing results (51-60 of 223) with videos related to
Sort By:
Pageof 23
The Journal of Headache and Pain|July 28, 2022
Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF studyRoger Cady, Richard B Lipton, Dawn C Buse, et al.Headache|October 22, 2020
Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) StudyDawn C Buse, Michael L Reed, Kristina M Fanning, et al.Headache|June 29, 2016
A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related DisabilityRichard B Lipton, Aubrey Manack Adams, Dawn C Buse, et al.Headache|September 8, 2017
Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS StudyRichard B Lipton, James S McGinley, Kenneth J Shulman, et al.Headache|June 21, 2018
Acceptance, Psychiatric Symptoms, and Migraine Disability: An Observational Study in a Headache CenterElizabeth K Seng, Alexander J Kuka, Sarah Jo Mayson, et al.International Journal of General Medicine|March 4, 2015
Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxietyGuy P Boudreau, Brian M Grosberg, Peter J McAllister, et al.Psychiatric Services (Washington, D.C.)|May 30, 2003
A comparison of gynecological variables and service use among older women with and without schizophreniaLaurie A Lindamer, Dawn C Buse, Lisa Auslander, et al.Journal of Occupational and Environmental Medicine|September 14, 2011
A case study for calculating employer costs for lost productive time in episodic migraine and chronic migraine: results of the American Migraine Prevalence and Prevention StudyWalter F Stewart, Christa Bruce, Aubrey Manack, et al.Neurology|January 23, 2015
Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraineRichard B Lipton, Kristina M Fanning, Daniel Serrano, et al.Headache|October 13, 2016
Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.Pageof 23